Allergan opens new Botox plant in Westport
January 29, 2020Research and Development AbbVie Ireland, Allergan AbbVie, Allergan. Abbvie
Allergan has officially opened a new €145m facility in Westport, Ireland to boost production of Botox. The new building rxpands …
Janssen’s Erleada expanded in Europe to cover metastatic hormone-sensitive prostate cancer
January 29, 2020Research and Development, Sales and Marketing Erleada, Europe, Janssen, pharma
Janssen’s Erleada (apalutamide) has secured expanded authorisation from the European Commission (EC), approving its label to include the treatment of …
BioIntelliSense’ BioSticker sensor approved by the FDA
January 29, 2020Research and Development Biosticker, home care, sensors
BioIntelliSense has secured 510 (k) clearance from the FDA for its biosticker sensor for remote care. The product is an …
FDA approves Teva’s Ajovy autoinjector for treatment of migraine
January 29, 2020Research and Development, Sales and Marketing FDA, Teva, ajovy, migraine, pharma
Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the …
British Airways suspends all flights to mainland China
January 29, 2020Research and Development British Airways, MERS, Sars, Wuhan Virus, coronavirus, virus
British Airways has ceased all flights to mainland China until 31 January. This comes after the Foreign Office advice against …
Prostate Cancer becomes most commonly diagnosed cancer in England
January 28, 2020Manufacturing and Production Cancer, Cancer diagnoses, NHS England, breast cancer, prostate cancer
Prostate cancer has overtaken breast cancer to be the most commonly diagnosed cancer for the first time in England, latest …
Lilly & Incyte’s Olumiant hits main goal in atopic dermatitis
January 28, 2020Manufacturing and Production, Research and Development Eli Lilly, Olumiant, pharma
Eli Lilly and Incyte have lifted the curtain on new Phase 3 data showing that their oral JAK inhibitor, showing …
Johnson & Johnson CEO testifies for the first time in Baby Powder Cancer trial
January 28, 2020Manufacturing and Production J&J, JJ, Johnson & Johnson, Talc Powder Cancer, baby powder, talc powder
Johnson & Johnson CEO Alex Gorsky faced questions around stock sales and his knowledge of asbestos in the company’s baby …
NICE rejects Janssen’s esketamine nasal spray Spravato for treatment-resistant depression
January 28, 2020Manufacturing and Production, Sales and Marketing Janssen, NHS, NICE, Spravato, depression
Janssen’s Spravato (esketamine) nasal spray, derived from the party drug ketamine, has been turned down by NICE for NHS use …
“Pharma Bro” Martin Shkreli charged by FTC for price fixing Daraprim
January 28, 2020Manufacturing and Production FTC, Martin Shkreli, New York Attorney General, Pharma Bro
Martin Shkreli, also known as the “Pharma Bro”, has been charged by the Federal Trade Commission for price fixing. The …
FDA approves MS drug for human trials
January 27, 2020Sales and Marketing MS, MS symptoms, MS treatment, Neuro, neurology
A drug that can make it easier to diagnose Multiple Sclerosis (MS) has been approved for its first human trials …
Realising the potential of greater collaboration for women living with cancer
January 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Merck KGaA, feature, pharma, women
Following the launch of a new global report, ‘Supporting women with cancer’, Lynn Talyroe, Senior Vice President, Head of Healthcare …
NICE refuses Novo Nordisk’s obesity therapy Saxenda for NHS use
January 27, 2020Sales and Marketing NHS, NICE, Novo Nordisk, UK, obesity, saxenda
NICE, the drug watchdog for England and Wales, has revealed that it has chosen not to recommend Novo Nordisk’s Saxenda …
Chinese coronavirus spread is accelerating as Xi Jinping labels it a “grave situation”
January 27, 2020Sales and Marketing Chinese Coronavrius, MARS, Sars, Viral pnemonia, respiration
The spread of the Chinese coronavirus is accelerating, as multiple countries set up checks and tests to contain the virus. …
FDA greenlights its first therapy for advanced epithelioid sarcoma population
January 27, 2020Sales and Marketing Cancer, Epizyme, FDA, Tazverik, pharma
The FDA has revealed the approval of its first therapy for the treatment of metastatic or locally advanced epithelioid sarcoma, …
Judge overseeing Purdue Pharma bankruptcy approves $1.3 million bonus for CEO
January 27, 2020Sales and Marketing Election 2020, OxyContin, Purdue Pharma, US Presidential Race, fentanyl, opioid crisis
Purdue Pharma’s CEO Craig Landau can receive a $1.3 million bonus, ruled a judge. Judge Robert Drain said the company …
Top Ten most popular articles on Pharmafile.com this week
January 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared …
European Commission expands Stelara for paediatric moderate to severe plaque psoriasis
January 24, 2020Research and Development Europe, Janssen, Stelara, pharma
Janssen’s Stelara (ustekinumab) has seen its label expanded in Europe to include the treatment of moderate to severe plaque psoriasis …
FDA puts MDMA therapy for PTSD on its Expanded Access program
January 24, 2020Medical Communications Expanded Access, MAPS, MDMA, PTSD, pharmaceuticals, psychedelics, war
The FDA has made MDMA treatment for PTSD more accessible by putting it on the Expanded Access program. 10 sites …
Roche’s Tecentriq falls short as an adjuvant monotherapy in muscle-invasive urothelial cancer
January 24, 2020Medical Communications, Sales and Marketing Cancer, Roche, pharma, tecentriq, trial failure
Roche has released an update on the development of its immunology Tecentriq (atezolizumab), making it known that the drug failed …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
